• Info
  • Insider Trading

Mark Enyedy - Insider Trading & Ownership

Location
C/O Fate Therapeutics, Inc., 3535 General Atomics Court, Suite 200, San Diego, CA
Summary
The estimated net worth of Mark Enyedy is at least $2.16M dollars as of June 4, 2025. Mark Enyedy is the CHIEF EXECUTIVE OFFICER, Director of ImmunoGen, Inc. and owns shares of ImmunoGen, Inc. stock worth about $898K. Mark Enyedy is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $853K. Mark Enyedy is the Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and owns shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) stock worth about $409K.
Signature
/s/ Mark Enyedy
All Insider Reports
All Insider Reports

Notify me when Mark Enyedy files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Mark Enyedy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IMGN ImmunoGen, Inc. CHIEF EXECUTIVE OFFICER, Director $898K Feb 12, 2024
BMRN BIOMARIN PHARMACEUTICAL INC Director $853K May 20, 2025
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director $409K Jun 2, 2025
LOGC LogicBio Therapeutics, Inc. Director Nov 16, 2022

Insider Transactions Reported by Mark Enyedy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.